Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Jan 16, 2018 9:54pm
360 Views
Post# 27373558

RE:RE:RE:RE:RE:DOD pushes FDA to approve freeze dried Plasma

RE:RE:RE:RE:RE:DOD pushes FDA to approve freeze dried Plasma Totally hear you Stag, and thats exactly what makes a market!

I do however 100% agree with you about the monetization deal tho.
I know that they are balancing the pluses and minuses in terms of the magnitude of a prospective deal, all while balancing the fact that their US underwriting syndicate is encouraging them to hang on to as much IP as
possible.    The Americans get IP value build and the earnings power /acquisition
attractiveness that comes from it.

i have heard Pierre say over and over, its much harder to develop a disruptive IP pipeline than it is to fix a balance sheet.  The likes of Goldman are telling him the same.

We are about to find out if they’re right

btw..u guys only get 50 cents a post for pumping?  U need a new agent

Bullboard Posts